March is National Colorectal Cancer Awareness Month. The 5-year survival rate for a colorectal cancer patient when detected at an early stage is 90%, which drastically plummets down to 14% if cancer gets spread to a distant part of the body. Only 39% of patients are...

BioGenex worked with Fremont city officials to ensure the supply of raw materials that were key to Roche's Covid-19 diagnostic. The call came on a Monday in mid-March: A Covid-19 test by BioGenex Laboratories' big customer, Roche Molecular Solutions, had secured...

BioGenex, a pioneer in automated staining solution provider for cancer diagnostics announces the launch of three new primary immunohistochemistry (IHC) antibodies for cancer diagnosis. The new launch includes: CD8A: Studies have confirmed that CD8 expression is a...